The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of AZD0486, a CD19xCD3 T-cell engager, in relapsed or refractory diffuse large B-cell lymphoma.
 
Tae Min Kim
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Chong Kun Dang Pharmaceutical; Daiichi Sankyo/Astra Zeneca; inno.N; Janssen Oncology; Merck KGaA; Novartis; Regeneron; Roche; Samsung Bioepis; Takeda
Speakers' Bureau - Amgen; AstraZeneca/MedImmune; Janssen Research & Development; Takeda
(OPTIONAL) Uncompensated Relationships - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Black Diamond Therapeutics (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Boryung (Inst); Bristol Myers Squibb Foundation (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Dizal Pharma (Inst); Enliven Therapeutics (Inst); Fore Biotherapeutics (Inst); Genmab (Inst); Hanmi (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); RAPT Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); Yuhan (Inst)
 
Dok Hyun Yoon
Honoraria - Celgene; Janssen; Kirin Pharmaceuticals; Roche; Takeda
Consulting or Advisory Role - ABclonal; Amgen; Celgene; GI cell; Janssen; Novartis; Pharos iBio; Roche
Research Funding - Boryung; Celltrion (Inst); Janssen Oncology; Roche/Genentech; Samyang
 
Sameh Gaballa
Honoraria - ADC Therapeutics; Lilly
Speakers' Bureau - ADC Therapeutics; Lilly
Research Funding - Adaptive Biotechnologies; AstraZeneca; Ipsen; Kite, a Gilead Company
Travel, Accommodations, Expenses - Lilly
 
Seok-Goo Cho
No Relationships to Disclose
 
Ranjit Nair
Consulting or Advisory Role - 280 Bio; ADC Therapeutics; Novartis
 
Dai Maruyama
Honoraria - AbbVie; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Genmab; Janssen; Kyowa Kirin; MSD; Mundipharma; Nippon Shinyaku; Novartis; Ono Pharmaceutical; Pfizer; Roche; Sanofi; SymBio Pharmaceuticals; Takeda; Zenyaku Kogyo
Consulting or Advisory Role - AbbVie; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Genmab; Janssen; Pfizer; Roche; Sanofi
Research Funding - AbbVie; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Genmab; Janssen; Kyowa Kirin; MSD; Novartis; Ono Pharmaceutical; Otsuka; Pfizer; Roche; Sanofi; SymBio Pharmaceuticals; Taiho Pharmaceutical; Takeda; Zenyaku Kogyo
 
Ryan Jacobs
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; BeiGene; Genentech; Genmab; Pharmacyclics; Secura Bio
Speakers' Bureau - Abbvie; AstraZeneca; BeiGene; Genmab
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Lilly (Inst); Pharmacyclics (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Abbvie; Adaptive Biotechnologies; AstraZeneca; BeiGene; Genmab; Genmab; Janssen; Secura Bio
 
Sumana Devata
Stock and Other Ownership Interests - AbbVie; AstraZeneca; Bayer; GlaxoSmithKline; Johnson & Johnson; Lilly; Merck; Novo Nordisk; Pfizer
Research Funding - AstraZeneca
 
Koji Izutsu
Honoraria - AbbVie; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Genmab; Gilead Sciences; Janssen; Kyowa Kirin; Lilly; Meiji Seika Kaisha; MSD; Nihonkayaku; Ono Pharmaceutical; Otsuka; Pfizer; SymBio Pharmaceuticals; Takeda; Zenyaku Kogyo
Consulting or Advisory Role - AbbVie; BeiGene; Bristol-Myers Squibb; Carna Biosciences; Chugai Pharma; Eisai; Genmab; Mitsubishi Tanabe Pharma; MSD; Nippon Shinyaku; Novartis; Ono Pharmaceutical; Otsuka; SymBio Pharmaceuticals; Takeda; Zenyaku Kogyo
Research Funding - AbbVie; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Genmab; Incyte; Janssen; Kite/Gilead; Kyowa Kirin; Loxo; MSD; Otsuka; Pfizer; Regeneron; SymBio Pharmaceuticals; Yakult Pharmaceutical
 
Yazeed Sawalha
Honoraria - Genentech
Consulting or Advisory Role - ADC Therapeutics; Genmab
Research Funding - Abbvie (Inst); BeiGene (Inst); Genmab (Inst)
 
Won Kim
Research Funding - BeiGene; BeiGene; Boryung; Sanofi
 
Don Stevens
No Relationships to Disclose
 
Constantine Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Loxo/Lilly; Roche/Genentech
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); BeiGene (Inst); Janssen-Cilag (Inst)
 
Eliza Hawkes
Consulting or Advisory Role - AstraZeneca; BeiGene (Inst); Bristol Myers Squibb (Inst); Gilead Sciences (Inst); Janssen Oncology; Link healthcare (Inst); Merck Sharpe & Dohme (Inst); Novartis (Inst); Regeneron (Inst)
Speakers' Bureau - Abbvie (Inst); Regeneron; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); Merck KGaA (Inst); Mundipharma (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Hisayuki Yokoyama
Honoraria - Astellas Pharma
Research Funding - Astellas Pharma; Janssen; Novartis; Pfizer
 
Aravind Ramakrishnan
Consulting or Advisory Role - Sonoma Biotech
Research Funding - AstraZeneca (Inst); Autolus Therapeutics (Inst); Bristol-Myers Squibb/Celgene/Juno (Inst); Cellectis (Inst); Chimeric (Inst); Fate Therapeutics (Inst); Janssen (Inst); Juno Therapeutics (Inst); Kadmon (Inst); Kite/Gilead (Inst); Macrogenics (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Poseida (Inst); Sanofi (Inst); Schrodinger (Inst); Sumitomo Pharma Oncology (Inst)
 
Matthew Matasar
Stock and Other Ownership Interests - Merck
Honoraria - ADC Therapeutics; Bayer; Bristol-Myers Squibb/Celgene/Juno; Epizyme; Genentech; GlaxoSmithKline; Immunovaccine; Janssen; Pharmacyclics; Roche; Seagen; Takeda
Consulting or Advisory Role - Arvinas; Bayer; Daiichi Sankyo; Epizyme; Genentech; Juno Therapeutics; Merck; Roche; Rocket Medical; Seagen; Takeda; Teva; Treeline Biosciences
Research Funding - Bayer; Genentech; GlaxoSmithKline; IGM Biosciences; IGM Biosciences; Immunovaccine; Janssen; Pharmacyclics; Roche; Rocket Medical; Seagen
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Bayer; Genentech; Roche; Seagen
 
Mihail Obrocea
Employment - AstraZeneca
Leadership - MAIA Biotechnology
Stock and Other Ownership Interests - MAIA Biotechnology
 
Jing-Zhou Hou
Consulting or Advisory Role - AstraZeneca; Rigel